reference/437684

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/437684

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	249
issn	1083-7159 1549-490X
issueIdentifier	2
pageRange	239-249
publicationName	The Oncologist
startingPage	239
bibliographicCitation	Vassilakopoulos TP, Pangalis GA, Katsigiannis A, Papageorgiou SG, Constantinou N, Terpos E, Zorbala A, Vrakidou E, Repoussis P, Poziopoulos C, Galani Z, Dimopoulou MN, Kokoris SI, Sachanas S, Kalpadakis C, Dimitriadou EM, Siakantaris MP, Kyrtsonis MC, Dervenoulas J, Dimopoulos MA, Meletis J, Roussou P, Panayiotidis P, Beris P, Angelopoulou MK. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care. Oncologist. 2012;17(2):239–49. PMID: 22282906; PMCID: PMC3286173.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cfa8c66c7116ee02da709165b3d0397 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d432b41450929e06b0bfccb1cac4ddb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb41d4c24c9df26dd7d3600e8ca38dc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e53a164110b4e8fe26a2ac7718d31f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63157ad19b3039f03419273e9c4d7e5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_233d62611592d995d38b829b2fd192ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4e7916295d6b43a3850b86f47a7068e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87ba0c4be9475d6ed192ed8f412e1a84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adb353e0bf87c481fed14a4b3981533c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62723f3349ddb201a9fa4e703f8926f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_511cb03326924cb2e5c79d64e5006c6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7af3f7ca68c69794282582b898d005dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e840988d780e82485fbcdd75f7a12e3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f8e021b5a396af79abc986f99ab9344 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d8deea443448c7de2159027c446b5d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b32289e7a9ad033119dc864cd2abfd89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63bd2d80a74cf81a50965a999a1f6cf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97dafafd77f546072c20c1b06450fd0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1503edc5250818ac335255857da286fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee7a8c2fbf438041f75845c94661bb87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02740a1728672c2b215d4e974decb6cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20e9ad2122b575dc8acae94ad7aa943b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_054126bfed68a78564625d5b9828aec8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f24a28e88fc7d219d4fb32b8ca84d705 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a800e450774b4436c545e9cab1cc450a
date	2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22282906 https://pubmed.ncbi.nlm.nih.gov/PMC3286173 https://doi.org/10.1634/theoncologist.2011-0275
isPartOf	https://portal.issn.org/resource/ISSN/1083-7159 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21392 https://portal.issn.org/resource/ISSN/1549-490X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care
discusses	http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0244307
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016403Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016403Q000401 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016403Q000532 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D011239Q000008 http://id.nlm.nih.gov/mesh/D058846Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D049268 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D059248 http://id.nlm.nih.gov/mesh/D014057 http://id.nlm.nih.gov/mesh/D064847 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903698 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456190 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84068 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360373 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460769 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129367670

Total number of triples: 96.